Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Update

16 Jan 2006 07:00

Gyrus Group PLC16 January 2006 16th January 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its preliminary results announcement on 16th March 2006. The Group's reported revenues for the year to 31st December 2005 are anticipatedto be approximately £149 million representing over 70% growth on the previousyear (2004: £86.9 million). Underlying revenue growth (excluding the effect ofthe acquisition of American Cystoscope Makers Inc ("ACMI"), which completed on21st July 2005, and on a constant exchange rate basis) is expected to bemarginally over 14%. The full year results will include a 23 week contributionfrom ACMI, amounting to revenues of approximately £49 million. The acquisition of ACMI was a significant event in the Group's development, andits performance since the acquisition has been in line with the Group'sexpectations. The integration of ACMI is on track with the plans outlined at theinterim results in September. It remains Gyrus' view that the combinedbusinesses will yield significant improvements in profitability over thethree-year integration period post acquisition. Subject to any unforeseen audit adjustments in respect of IFRS, acquisition andtax accounting, it is anticipated that underlying earnings per share for theyear to 31st December 2005 will be towards the higher end of analysts'expectations which currently range between 9.4p and 13.3p on an adjusted basis. Brian Steer, Executive Chairman of Gyrus said: "For the Board and management, 2005 has been exciting both operationally andstrategically. The business has performed extremely well and we took advantageof the outstanding opportunity to acquire ACMI mid way through the year. Thesuccessful initial integration of ACMI is a testament to the strength andcapability of the combined management team, particularly at the divisionallevel. We look forward to continuing our strong performance in 2006." Enquiries: Gyrus Group PLC Brian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial Dynamics Ben Atwell 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Nov 200512:02 pmRNSHolding(s) in Company
19th Oct 20056:01 pmRNSHolding(s) in Company
11th Oct 20054:45 pmRNSHolding(s) in Company
7th Oct 20056:19 pmRNSHolding(s) in Company
4th Oct 20055:18 pmRNSHolding(s) in Company
13th Sep 20054:44 pmRNSDirector/PDMR Shareholding
18th Aug 20053:51 pmRNSHolding(s) in Company
17th Aug 20055:51 pmRNSHolding(s) in Company
11th Aug 20055:42 pmRNSHolding(s) in Company
10th Aug 20057:01 amRNSHolding(s) in Company
29th Jul 20054:57 pmRNSHolding(s) in Company
29th Jul 20057:00 amRNSHolding(s) in Company
28th Jul 20054:40 pmRNSHolding(s) in Company
22nd Jul 20055:04 pmRNSHolding(s) in Company
21st Jul 20058:05 amRNSAcquisition & Trading Update
19th Jul 20056:25 pmRNSHolding(s) in Company
19th Jul 20056:21 pmRNSHolding(s) in Company
15th Jul 20054:14 pmRNSHolding(s) in Company
12th Jul 20059:07 amRNSAcquisition Update
4th Jul 20056:27 pmRNSHolding(s) in Company
4th Jul 200512:46 pmRNSResult of EGM
30th Jun 200511:18 amRNSHolding(s) in Company
16th Jun 20057:13 amRNSProposed Acquisition
2nd Jun 20054:48 pmRNSDirector Shareholding
2nd Jun 20057:01 amRNSHolding(s) in Company
13th May 20052:44 pmRNSHolding(s) in Company
12th Apr 20056:20 pmRNSHolding(s) in Company
12th Apr 20055:36 pmRNSHolding(s) in Company
4th Apr 20055:37 pmRNSDirector Shareholding
17th Mar 200511:45 amRNSDirector Shareholding
16th Mar 20057:01 amRNSBoard Change
16th Mar 20057:01 amRNSAcquisition
16th Mar 20057:01 amRNSFinal Results
24th Feb 20053:05 pmRNSHolding(s) in Company
8th Feb 200512:58 pmRNSHolding(s) in Company
14th Jan 20057:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.